Two giants of commercial gene research, Celera Genomics of Rockville,
Maryland, and Geron of Menlo Park, California, signed a deal this week to work
towards growing brand new organs from a patient’s own cells. Geron has a unique
supply of human stem cells, which can theoretically grow into particular sorts
of tissue, while sequencing heavyweight Celera will identify genes which control
tissue formation in embryos. “Our work under this alliance will bring us one
step closer to realising the therapeutic potential of human stem cells,” says
Thomas Okarma, Geron’s president.
More from New Scientist
Explore the latest news, articles and features
Physics
Record-breaking, fast-spinning magnet could help uncover new physics
News
Environment
An unexpected feedback loop may be driving mega heatwaves
News
91ɫÇéƬ
Less than 4 minutes of vigorous exercise a day could halve your dementia risk
News
91ɫÇéƬ
Parkinson’s may be driven by ‘vicious cycle’ that disrupts brain waste drainage
News
Popular articles
Trending New Scientist articles